Show
Sort by
-
- Journal Article
- A1
- open access
Oral corticosteroid reduction and discontinuation in adults with corticosteroid-dependent, severe, uncontrolled asthma treated with tezepelumab (WAYFINDER) : a multicentre, single-arm, phase 3b trial
-
Incorrect interpretation of the role of COVID-19 vaccination boosters in saving lives
-
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints : opportunities and challenges
-
Genetic and environmental risk factors for asthma : towards prevention
-
- Journal Article
- A1
- open access
Eosinophils in asthma phenotypes : perpetrators or guilty by association?
-
- Journal Article
- A1
- open access
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103) : results from two randomised, active-controlled, phase 3 trials
-
- Journal Article
- A1
- open access
Inflammatory and clinical risk factors for asthma attacks (ORACLE2) : a patient-level meta-analysis of control groups of 22 randomised trials
-
Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST) : a multicentre, randomised, double-blind, head-to-head phase 4 trial
-
Strengthening intensive care : addressing challenges and embracing opportunities
-
- Journal Article
- A1
- open access
Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis : randomised, double-blind, controlled, phase 2 trials